Nasopharyngeal carcinoma - Review of the molecular mechanisms of tumorigenesis

被引:260
作者
Chou, Josephine [1 ]
Lin, Yu-Ching [1 ,2 ,3 ]
Kim, Jae [1 ]
You, Liang [1 ]
Xu, Zhidong [1 ]
He, Biao [1 ]
Jablons, David M. [1 ]
机构
[1] Univ Calif San Francisco, Ctr Comprehens Canc, Thorac Oncol Lab, Dept Surg, San Francisco, CA 94115 USA
[2] Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Chiayi, Taiwan
[3] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2008年 / 30卷 / 07期
关键词
nasopharyngeal carcinoma (NPC); Epstein-Barr virus (EBV); LMP1; tumorigenesis; review;
D O I
10.1002/hed.20833
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Nasopharyngeal carcinoma (NPC) is a head and neck cancer rare throughout most of the world but common in certain geographic areas, such as southern Asia. While environmental factors and genetic susceptibility play important roles in NPC pathogenesis, the Epstein-Barr virus in particular has been implicated in the molecular abnormalities leading to NPC. There is upregulation of cellular proliferation pathways such as the Akt pathway, mitogen-activated protein kinases, and the Wnt pathway. Cell adhesion is compromised due to abnormal E-cadherin and beta-catenin function. Aberrations in cell cycle are due to dysregulation of factors such as p 16, cyclin D1, and cyclin E. Anti-apoptotic mechanisms are also upregulated. There are multiple abnormalities unique to NPC that are potential targets for novel treatments. (c) 2008 Wiley Periodicals, Inc.
引用
收藏
页码:946 / 963
页数:18
相关论文
共 213 条
  • [1] Regulation of Survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines
    Ai, MD
    Li, LL
    Zhao, XR
    Wu, Y
    Gong, JP
    Cao, Y
    [J]. CELL RESEARCH, 2005, 15 (10) : 777 - 784
  • [2] Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099
    Al-Sarraf, M
    LeBlanc, M
    Giri, PGS
    Fu, KK
    Cooper, J
    Vuong, T
    Forastiere, AA
    Adams, G
    Sakr, WA
    Schuller, DE
    Ensley, JF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1310 - 1317
  • [3] UNDIFFERENTIATED NASOPHARYNGEAL CANCER (UCNT) - CURRENT DIAGNOSTIC AND THERAPEUTIC ASPECTS
    ALTUN, M
    FANDI, A
    DUPUIS, O
    CVITKOVIC, E
    KRAJINA, Z
    ESCHWEGE, F
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (03): : 859 - 877
  • [4] A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
    Ambrosini, G
    Adida, C
    Altieri, DC
    [J]. NATURE MEDICINE, 1997, 3 (08) : 917 - 921
  • [5] Baba Y, 2001, CANCER DETECT PREV, V25, P414
  • [6] Bai Weiliang, 2006, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V20, P254
  • [7] Bancroft CC, 2001, CLIN CANCER RES, V7, P435
  • [8] Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma
    Bang, YJ
    Kwon, JH
    Kang, SH
    Kim, JW
    Yang, YC
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (01) : 43 - 47
  • [9] Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells
    Bargou, RC
    Emmerich, F
    Krappmann, D
    Bommert, K
    Mapara, MY
    Arnold, W
    Royer, HD
    Grinstein, E
    Greiner, A
    Scheidereit, C
    Dörken, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) : 2961 - 2969
  • [10] Matrix metalloproteinase-1(-1607) 1G/2G and -9(1562) C/T promoter polymorphisms: Susceptibility and prognostic implications in nasopharyngeal carcinomas
    Ben Nasr, Hela
    Mestiri, Souhir
    Chahed, Karim
    Bouaouina, Noureddine
    Gabbouj, Sallouha
    Jalbout, Majida
    Chouchane, Lotfi
    [J]. CLINICA CHIMICA ACTA, 2007, 384 (1-2) : 57 - 63